1. Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic disorders. BMJ. 2003. 326:1372–1376.
Article
2. MacDonald PH. Ischaemic colitis. Best Pract Res Clin Gastroenterol. 2002. 16:51–61.
Article
3. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev. 2005. 6:93–111.
Article
4. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000. 343:1833–1838.
Article
5. Ryan CK, Reamy B, Rochester JA. Ischemic colitis associated with herbal product use in a young woman. J Am Board Fam Pract. 2002. 15:309–312.
6. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003. 289:1537–1545.
Article
7. Krome CN, Tucker AM. Cardiac arrhythmia in a professional football player: Was ephedrine to blame? Phys Sportsmed. 2003. 31:21–25. 29
8. Rezkalla SH, Mesa J, Sharma P, Kloner RA. Myocardial infarction temporally related to ephedra-a possible role for the coronary microcirculation. WMJ. 2002. 101:64–66.
9. Naik SD, Freudenberger RS. Ephedra-associated cardiomyopathy. Ann Pharmacother. 2004. 38:400–403.
Article
10. Chen C, Biller J, Willing SJ, Lopez AM. Ischemic stroke after using over the counter products containing ephedra. J Neurol Sci. 2004. 217:55–60.
Article
11. Charatan F. Ephedra supplement may have contributed to sportsman's death. BMJ. 2003. 326:464.
Article
12. Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes Relat Metab Disord. 2002. 26:1363–1366.
Article
13. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002. 71:421–432.
Article
14. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004. 291:216–221.
Article
15. Jellin JM, Gregory P, Batz F, Hitchens K, editors. Ephedra. Natural medicines comprehensive database. 2000. 3rd ed. Stockton, CA: Therapeutic Research Faculty;400–403.
16. Lichtenstein GR, Yee NS. Ischemic colitis associated with decongestant use. Ann Intern Med. 2000. 132:682.
Article
17. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan JA. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol. 1999. 94:2430–2434.
Article
18. Comay D, Ramsay J, Irvine EJ. Ischemic colitis after weight-loss medication. Can J Gastroenterol. 2003. 17:719–721.
Article